Nuvalent Inc vs Synchrony Financial — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Synchrony Financial trades at $71.7 (market cap $24.69B). The key difference: Synchrony Financial is far larger — about 2.5× Nuvalent Inc's market cap, and Synchrony Financial pays a 1.63% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | SYF | |
|---|---|---|
Market Cap | $9.81B | $24.69B |
Sector | Technology | Financials |
52-Week High | $123.96 | $88.47 |
52-Week Low | $72.16 | $63.78 |
Enterprise Value | $8.52B | — |
Dividend Yield | — | 1.63% |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.
Read more on SYF →